Phase I trial of AVN 322.
Latest Information Update: 15 Feb 2011
At a glance
- Drugs AVN 322 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- Sponsors Avineuro Pharmaceuticals
Most Recent Events
- 09 Feb 2010 New trial record
Latest Information Update: 15 Feb 2011